Detail akcie iRhythm Technolg Rg online

Business Summary: iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Irhythm Technologies Inc revenues increased 20% to $492.7M. Net loss increased 6% to $123.4M. Revenues reflect Contracted third-party payors segment increase of 19% to $267.2M, Centers for Medicare & Medicaid segment increase of 19% to $122.4M. Higher net loss reflects Selling, general and administrative - B increase of 12% to $307.6M (expense).